Suggestions
Craig Mosman
VP of Business Development at Cibus Biotechnologies
Professional Background
Craig Mosman is a seasoned executive in the biotechnology sector, holding the position of Vice President of Business Development at Cibus Biotechnologies, a company at the forefront of innovative agricultural solutions. Cibus Biotechnologies is known for its exclusive world-wide license for groundbreaking technology developed at the University of Arizona, aimed at curtailing the replication of viruses, which is a critical concern in agricultural contexts. The strategic focus of the company includes targeting significant viral threats such as White Spot Syndrome Virus (WSSV) and African Swine Fever, diseases that pose major risks to the health of global food supply systems. Under Craig's leadership, Cibus continues to enhance its research and development initiatives, recently announcing that additional patents are expected to be filed as its technologies advance in their efficacy and applicability.
Craig's career is marked by a series of significant leadership roles within prestigious biotechnology enterprises. Prior to his tenure at Cibus, he served as the President at Kirkland Biosciences LLC, where he was instrumental in driving business initiatives and fostering innovative biotechnological advancements. His experience is not limited to this role; Craig has also co-founded ProBio Systems, LLC, and has held the title of Vice President and Chief Business Development Officer at DxNA LLC. These roles underline his extensive expertise in biotechnology, business development, and strategic partnerships within the industry.
Education and Achievements
Craig Mosman studied for his Bachelor of Arts degree in Education at Utah State University. This educational background provides him with a unique perspective on effective communication and knowledge dissemination, essential skills in the fast-evolving field of biotechnology.
With the growing emphasis on sustainable and pathogen-free agricultural practices, Craig's work at Cibus Biotechnologies is particularly timely. The company has developed a portable, cost-efficient pathogen detection system dedicated to the rapid diagnosis of diseases that affect both plants and animals. This innovative platform has garnered attention for its practicality in ensuring the health of agricultural stocks, thus supporting food safety and security globally. As the company continues to innovate, the ongoing collaboration with the University of Arizona to develop WSSV assays represents a crucial step in pathogen detection and management strategies for shrimp farming, which is vital for both the industry and the economies dependent on aquaculture.
Achievements
Craig Mosman’s notable achievements include successfully navigating the complexities of biotech commercialization and bringing to market technologies that directly address pressing agricultural health issues. His leadership in patenting significant advancements underscores his commitment to research and development that not only protects crops and livestock but also supports environmental sustainability. The comprehensive skills Craig has honed throughout his career enable him to forge strategic partnerships that accelerate technology adoption across the agricultural landscape.
In summary, Craig Mosman is a dynamic leader making substantial contributions to biotechnology with a strong focus on agricultural innovations. His combined skill set in education, business development, and biotechnological research positions him as a key player in advancing sustainable agricultural practices and improving the health of crops and livestock around the world.
